These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23463208)

  • 1. Thioridazine lacks bactericidal activity in an animal model of extracellular tuberculosis.
    Dutta NK; Pinn ML; Zhao M; Rudek MA; Karakousis PC
    J Antimicrob Chemother; 2013 Jun; 68(6):1327-30. PubMed ID: 23463208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced emergence of isoniazid resistance with concurrent use of thioridazine against acute murine tuberculosis.
    Dutta NK; Pinn ML; Karakousis PC
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4048-53. PubMed ID: 24798290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
    Ahmad Z; Fraig MM; Pinn ML; Tyagi S; Nuermberger EL; Grosset JH; Karakousis PC
    J Antimicrob Chemother; 2011 Jul; 66(7):1560-6. PubMed ID: 21602551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent activity of pyrazinamide in animal models of intracellular and extracellular tuberculosis infections.
    Ahmad Z; Fraig MM; Bisson GP; Nuermberger EL; Grosset JH; Karakousis PC
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1527-32. PubMed ID: 21282447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.
    Musuka S; Srivastava S; Siyambalapitiyage Dona CW; Meek C; Leff R; Pasipanodya J; Gumbo T
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5870-7. PubMed ID: 24041886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis.
    Singh A; Sharma S
    Tuberculosis (Edinb); 2014 Dec; 94(6):695-700. PubMed ID: 25305001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
    de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
    Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen.
    Dutta NK; Alsultan A; Gniadek TJ; Belchis DA; Pinn ML; Mdluli KE; Nuermberger EL; Peloquin CA; Karakousis PC
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3910-6. PubMed ID: 23733473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs.
    Dutta NK; Illei PB; Peloquin CA; Pinn ML; Mdluli KE; Nuermberger EL; Grosset JH; Karakousis PC
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3726-31. PubMed ID: 22547623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterilizing activity of thioridazine in combination with the first-line regimen against acute murine tuberculosis.
    Dutta NK; Pinn ML; Karakousis PC
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5567-9. PubMed ID: 24936590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potent bactericidal activity of streptomycin in the guinea pig model of tuberculosis ceases due to the presence of persisters.
    Ahmad Z; Pinn ML; Nuermberger EL; Peloquin CA; Grosset JH; Karakousis PC
    J Antimicrob Chemother; 2010 Oct; 65(10):2172-5. PubMed ID: 20693172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the 'Denver regimen' against acute tuberculosis in the mouse and guinea pig.
    Ahmad Z; Nuermberger EL; Tasneen R; Pinn ML; Williams KN; Peloquin CA; Grosset JH; Karakousis PC
    J Antimicrob Chemother; 2010 Apr; 65(4):729-34. PubMed ID: 20123722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis.
    van Soolingen D; Hernandez-Pando R; Orozco H; Aguilar D; Magis-Escurra C; Amaral L; van Ingen J; Boeree MJ
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioridazine: the good and the bad.
    Thanacoody RH
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):92-8. PubMed ID: 21548877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.
    Yoshimatsu T; Nuermberger E; Tyagi S; Chaisson R; Bishai W; Grosset J
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1875-9. PubMed ID: 12019103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
    Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
    J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent tuberculosis: is there a role for thioridazine?
    Sohaskey C
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):139-46. PubMed ID: 21548878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig.
    Ahmad Z; Klinkenberg LG; Pinn ML; Fraig MM; Peloquin CA; Bishai WR; Nuermberger EL; Grosset JH; Karakousis PC
    J Infect Dis; 2009 Oct; 200(7):1136-43. PubMed ID: 19686043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoniazid pharmacokinetics-pharmacodynamics in an aerosol infection model of tuberculosis.
    Jayaram R; Shandil RK; Gaonkar S; Kaur P; Suresh BL; Mahesh BN; Jayashree R; Nandi V; Bharath S; Kantharaj E; Balasubramanian V
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2951-7. PubMed ID: 15273105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delamanid Kills Dormant Mycobacteria
    Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.